ZA93919B - Vaccines - Google Patents

Vaccines

Info

Publication number
ZA93919B
ZA93919B ZA93919A ZA93919A ZA93919B ZA 93919 B ZA93919 B ZA 93919B ZA 93919 A ZA93919 A ZA 93919A ZA 93919 A ZA93919 A ZA 93919A ZA 93919 B ZA93919 B ZA 93919B
Authority
ZA
South Africa
Prior art keywords
vaccines
Prior art date
Application number
ZA93919A
Inventor
Myriam Francotte
Moncef Slaoui
Nathalie Marie- Garcon-Johnson
Jean-Paul Prieels
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of ZA93919B publication Critical patent/ZA93919B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ZA93919A 1992-02-12 1993-02-10 Vaccines ZA93919B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9202933A GB9202933D0 (en) 1992-02-12 1992-02-12 Vaccines

Publications (1)

Publication Number Publication Date
ZA93919B true ZA93919B (en) 1993-11-26

Family

ID=10710240

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93919A ZA93919B (en) 1992-02-12 1993-02-10 Vaccines

Country Status (5)

Country Link
AU (1) AU3495993A (en)
GB (1) GB9202933D0 (en)
MX (1) MX9300744A (en)
WO (1) WO1993015749A1 (en)
ZA (1) ZA93919B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325496D0 (en) * 1993-12-14 1994-02-16 Smithkline Beecham Biolog Vaccines
ATE312189T1 (en) 2000-01-21 2005-12-15 Biovex Ltd VIRUS STRAINS FOR ONCOLYTIC TREATMENT OF CANCER
US11752206B2 (en) 2017-03-15 2023-09-12 Modernatx, Inc. Herpes simplex virus vaccine
WO2020190750A1 (en) 2019-03-15 2020-09-24 Modernatx, Inc. Hiv rna vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089854B1 (en) * 1982-03-24 1988-12-07 The University Of Birmingham Vaccine against dna viruses
ATE70308T1 (en) * 1984-09-12 1991-12-15 Chiron Corp HYBRID PARTICLE IMMUNOGENS.
CA1331443C (en) * 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9102126D0 (en) * 1991-01-31 1991-03-13 Smithkline Beecham Biolog Novel vaccine
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
PT100460B (en) * 1991-05-07 1999-07-30 Medical Res Council PARTICLES DERIVED FROM HERPES VIRUSES AND VACCINES THAT CONTAIN THEM

Also Published As

Publication number Publication date
WO1993015749A1 (en) 1993-08-19
MX9300744A (en) 1993-09-01
AU3495993A (en) 1993-09-03
GB9202933D0 (en) 1992-03-25

Similar Documents

Publication Publication Date Title
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
ZA947828B (en) Vaccines
GB9106048D0 (en) Vaccines
GB9325496D0 (en) Vaccines
GB9215233D0 (en) Vaccines
GB9214871D0 (en) Vaccines
ZA93919B (en) Vaccines
GB9213559D0 (en) Vaccines
GB9201023D0 (en) Vaccines
GB9322702D0 (en) Vaccines
ZA948729B (en) Vaccines
GB9226768D0 (en) Vaccines
GB9211081D0 (en) Vaccines
GB9217635D0 (en) Vaccines
GB9216317D0 (en) Vaccines
GB9221891D0 (en) Vaccines
GB9226283D0 (en) Vaccines
ZA935281B (en) Vaccines
GB9218833D0 (en) Vaccines
GB9220360D0 (en) Vaccines
GB9211318D0 (en) Vaccines
GB9206788D0 (en) Vaccine
GB9307028D0 (en) Vaccine
GB9206786D0 (en) Vaccine